|
|
|
Insider
Information: |
Kutzkey Tim |
Relationship: |
|
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
35,728,642 |
|
Indirect Shares
|
4,162,673 |
|
|
Direct
Value |
$435,589,501 |
|
|
Indirect Value
|
$124,372,793 |
|
|
Total
Shares |
39,891,315 |
|
|
Total
Value |
$559,962,294 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
10
|
1
|
Stock
price went up :
|
8
|
0
|
Stock
price went down : |
2
|
1
|
|
|
|
Gain/Loss Ratio : |
4.0
|
-1.0
|
Percentage
Gain/Loss : |
42.8%
|
-8.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arcus Biosciences Inc |
RCUS |
10% Owner |
2018-03-19 |
470,427 |
2018-03-19 |
0 |
Premium* |
|
Immune Design Corp. |
IMDZ |
10% Owner |
2017-10-27 |
6,642,942 |
2017-10-27 |
0 |
Premium* |
|
Constellation Pharmaceuticals Inc |
CNST |
10% Owner |
2021-02-17 |
2,584,957 |
2021-02-17 |
3,645,681 |
Premium* |
|
Ngm Biopharmaceuticals Inc |
NGM |
Managing Partner, 10% ... |
2020-09-02 |
18,052,932 |
2020-09-02 |
190,000 |
Premium* |
|
Revolution Medicines, Inc. |
RVMD |
Managing Partner, 10% ... |
2020-02-18 |
7,977,384 |
2020-02-18 |
0 |
Premium* |
|
Surrozen Ord Shs |
SRZN |
|
|
0 |
2024-04-04 |
326,992 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SRZN |
Surrozen Ord Shs |
|
|
2024-04-04 |
4/A |
B |
$15.50 |
$2,999,994 |
I/I |
193,548 |
326,992 |
0.01 |
- |
|
SRZN |
Surrozen Ord Shs |
|
|
2024-04-04 |
4 |
B |
$15.50 |
$2,999,994 |
I/I |
193,548 |
332,885 |
0.01 |
- |
|
SRZN |
Surrozen Ord Shs |
Director |
|
2021-08-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,248,129 |
|
% |
|
CNST |
Constellation Pharmaceuti... |
10% Owner |
|
2021-02-17 |
4 |
S |
$36.95 |
$369,503 |
I/I |
(10,000) |
99,155 |
0 |
% |
|
CNST |
Constellation Pharmaceuti... |
10% Owner |
|
2020-12-14 |
4 |
OE |
$1.55 |
$46,666 |
D/D |
30,107 |
2,584,957 |
0 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-09-02 |
4 |
B |
$17.67 |
$487,604 |
D/D |
27,595 |
1,827,025 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-09-01 |
4 |
B |
$17.64 |
$643,754 |
D/D |
36,494 |
1,799,430 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-08-28 |
4 |
B |
$17.89 |
$467,555 |
D/D |
26,135 |
1,762,936 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-08-27 |
4 |
B |
$17.79 |
$646,827 |
D/D |
36,359 |
1,736,801 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-08-25 |
4 |
B |
$18.00 |
$1,800 |
D/D |
100 |
1,700,442 |
2.37 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-08-24 |
4 |
B |
$17.96 |
$197,991 |
D/D |
11,024 |
1,700,342 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-08-21 |
4 |
B |
$17.97 |
$131,558 |
D/D |
7,321 |
1,689,318 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-08-17 |
4 |
B |
$17.89 |
$114,943 |
D/D |
6,425 |
1,681,997 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-08-14 |
4 |
B |
$17.49 |
$664,498 |
D/D |
37,993 |
1,675,572 |
2.45 |
% |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2020-08-13 |
4 |
B |
$17.89 |
$355,922 |
D/D |
19,895 |
1,637,579 |
2.45 |
% |
|
RVMD |
Revolution Medicines, Inc... |
Managing Partner |
|
2020-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,977,384 |
7,977,384 |
0 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-10-11 |
4 |
B |
$10.57 |
$187,343 |
D/D |
17,724 |
53,172 |
2.45 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-10-10 |
4 |
B |
$10.50 |
$186,102 |
D/D |
17,724 |
35,448 |
2.45 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-10-09 |
4 |
B |
$10.26 |
$181,848 |
D/D |
17,724 |
17,724 |
2.45 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-08-09 |
4 |
B |
$13.99 |
$2,126 |
D/D |
152 |
2,597,816 |
2.37 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-08-08 |
4 |
B |
$13.98 |
$168 |
D/D |
12 |
2,597,664 |
2.37 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-08-07 |
4 |
B |
$14.00 |
$3,143,000 |
D/D |
224,500 |
2,597,652 |
2.45 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-08-06 |
4 |
B |
$13.96 |
$4,328 |
D/D |
310 |
2,373,152 |
2.37 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-08-05 |
4 |
B |
$13.98 |
$81,400 |
D/D |
5,824 |
2,372,842 |
2.45 |
- |
|
NGM |
Ngm Biopharmaceuticals In... |
Managing Partner |
|
2019-07-30 |
4 |
B |
$13.91 |
$123,195 |
D/D |
8,855 |
2,362,636 |
2.45 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|